Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856043) titled '[11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction' on Sept. 27.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Stony Brook University
Condition:
Heart Failure With Reduced Ejection Fraction
Cognitive Impairment, Mild
Neuroinflammation
Vascular Contributions to Cognitive Impairment and Dementia (VCID)
Intervention:
Drug: [11C]PS13: [carbon-11]PS13
COX-1 PET radioligand
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollmen...